Granisetron Hydrochloride Injection Shortage
Last Updated: April 23, 2024
Status: Current
Products Affected - Description
-
- Granisetron Hydrochloride intravenous injection, Fresenius Kabi, 1 mg/mL, 1 mL single dose vial, 1 count, NDC 63323-0318-01
- Granisetron Hydrochloride intravenous injection, Hikma, 1 mg/mL, 1 mL single dose vial, 10 count, NDC 00143-9744-10
- Granisetron Hydrochloride intravenous injection, Hikma, 1 mg/mL, 4 mL multiple dose vial, 10 count, NDC 00143-9745-05
Reason for the Shortage
-
- Fresenius Kabi did not provide a reason for the shortage.
- Hikma did not provide a reason for the shortage.
- Viatris has granisetron injection available.
Available Products
-
- Granisetron Hydrochloride intravenous injection, Mylan (Viatris), 1 mg/mL, 1 mL single dose vial, 1 count, NDC 67457-0863-01
- Granisetron Hydrochloride intravenous injection, Mylan (Viatris), 1 mg/mL, 4 mL multiple dose vial, 1 count, NDC 67457-0864-04
Estimated Resupply Dates
-
- Fresenius Kabi has granisetron 1 mg/mL 1 mL vials on back order and the company estimates a release date of mid-June 2024.
- Hikma has granisetron 1 mg/mL 1 mL and 4 mL vials on back order and the company estimates a release date of late-May 2024.
Updated
Created April 23, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.